Stevens Christopher James
SEC CIK 2079768 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | COO | 505.8K | — | $128.3K | 4 | 2025-08-04 | 2026-08-11 |
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 16:15 | 2026-08-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Stevens Christopher James | COO | S - Sale | $3.50 | -36.7K | 505.8K | -7% | -$128.3K | |
| D | 2026-08-05 20:49 | 2026-08-03 | RCKT | ROCKET PHARMACEUTICALS, INC. | Stevens Christopher James | COO | A - Grant | $0.00 | +73.3K | 542.4K | +16% | $0 |
| D | 2026-02-13 | 2026-02-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Stevens Christopher James | COO | A - Grant | $0.00 | +62.0K | 469.1K | +15% | $0 |
| D | 2025-08-06 | 2025-08-04 | RCKT | ROCKET PHARMACEUTICALS, INC. | Stevens Christopher James | COO | A - Grant | $0.00 | +407.2K | 407.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations